ImmunoGen
IMGN
#2203
Rank
NZ$15.46 B
Marketcap
NZ$55.36
Share price
0.00%
Change (1 day)
151.43%
Change (1 year)

ImmunoGen (IMGN) - Total debt

Total debt on the balance sheet as of September 2023 : NZ$0.14 Billion

According to ImmunoGen 's latest financial reports the company's total debt is NZ$0.14 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

ImmunoGen - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2022-12-31NZ$24.01 M-12.68%
2021-12-31NZ$27.49 M-16.95%
2020-12-31NZ$33.1 M-16.94%
2019-12-31NZ$39.86 M1195.5%
2018-12-31NZ$3.07 M6.6%
2017-12-31NZ$2.88 M
2016-06-30NZ$0.13 B
2001-06-30NZ$0.02 M-97.61%
2000-06-30NZ$0.83 M121.54%
1999-06-30NZ$0.37 M96.44%
1998-06-30NZ$0.19 M-34.71%
1997-06-30NZ$0.29 M-94.83%
1996-06-30NZ$5.69 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$97.47 B 65,104.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$83.31 B 55,631.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$112.97 B 75,472.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$76.88 B 51,328.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$101.61 B 67,874.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$41.07 B 27,378.60%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$82.30 B 54,955.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ$0.20 B 34.57%๐Ÿ‡บ๐Ÿ‡ธ USA